Novel insights on GM1 and Parkinson's disease: A critical review

6Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

GM1 is a crucial component of neuronal membrane residing both in the soma and nerve terminals. As reported in Parkinson’s disease patients, the reduction of GM1 determines the failure of fundamental functional processes leading to cumulative cell distress up to neuron death. This review reports on the role of GM1 in the pathogenesis of the disease, illustrating the current data available but also hypotheses on the additional mechanisms in which GM1 could be involved and which require further study. In the manuscript we discuss these points trying to explain the role of diminished content of brain GM1, particularly in the nigro-striatal system, in Parkinson’s disease etiology and progression.

Cite

CITATION STYLE

APA

Fazzari, M., Di Biase, E., Lunghi, G., Mauri, L., Chiricozzi, E., & Sonnino, S. (2022, February 1). Novel insights on GM1 and Parkinson’s disease: A critical review. Glycoconjugate Journal. Springer. https://doi.org/10.1007/s10719-021-10019-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free